Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Champions Oncology (CSBR) Non Operating Income (2016 - 2026)

Champions Oncology has reported Non Operating Income over the past 17 years, most recently at $39000.0 for Q1 2026.

  • For Q1 2026, Non Operating Income rose 105.26% year-over-year to $39000.0; the TTM value through Jan 2026 reached $227000.0, up 102.68%, while the annual FY2025 figure was $73000.0, 52.08% up from the prior year.
  • Non Operating Income for Q1 2026 was $39000.0 at Champions Oncology, down from $70000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $81000.0 in Q2 2024 and troughed at -$105000.0 in Q4 2023.
  • A 5-year average of $13411.8 and a median of $14000.0 in 2023 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: tumbled 1066.67% in 2023 and later surged 1400.0% in 2025.
  • Year by year, Non Operating Income stood at -$9000.0 in 2022, then tumbled by 1066.67% to -$105000.0 in 2023, then skyrocketed by 106.67% to $7000.0 in 2024, then surged by 900.0% to $70000.0 in 2025, then tumbled by 44.29% to $39000.0 in 2026.
  • Business Quant data shows Non Operating Income for CSBR at $39000.0 in Q1 2026, $70000.0 in Q4 2025, and $75000.0 in Q3 2025.